Federal contract award
W81K0221P0132
INTERCEPT PLATELET PATHOGEN REDUCTION SETS AT TAMC, HI
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M MRCO PACIFIC |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $258.2K |
| Current contract value | $258.2K |
| Potential contract value / ceiling | $258.2K |
| Start date | Oct 1, 2021 |
| Current end date | Sep 30, 2025 |
| Potential end date | Sep 30, 2025 |
| Latest award activity | Jan 23, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 23, 2025 | P00009 | $-400 | INTERCEPT PLATELET PATHOGEN REDUCTION SET (TAMC), DEOBLIGATION OF FY22 FUNDS FROM BASE PERIOD. |
| Oct 23, 2024 | P00008 | $67.4K | INTERCEPT PLATELET PATHOGEN REDUCTION SETS (TAMC), FY25 FUNDS AVAILABLE, 01 OCT 2024 - 30 SEP 2025 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.